4//SEC Filing
Olson William C 4
Accession 0001441844-11-000002
CIK 0000835887other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:31 PM ET
Size
12.1 KB
Accession
0001441844-11-000002
Insider Transaction Report
Form 4
Olson William C
VP, Research & Development
Transactions
- Exercise/Conversion
Common Stock
2011-01-03$4.83/sh+2,582$12,466→ 49,655 total - Tax Payment
Common Stock
2011-01-03$5.68/sh−2,351$13,354→ 47,304 total - Exercise/Conversion
ESPP (right to buy)
2011-01-03−2,582→ 0 totalExercise: $4.83From: 2011-01-01Exp: 2011-01-01→ Common Stock (2,582 underlying) - Disposition to Issuer
ESPP (right to buy)
2011-01-03+5,308→ 5,308 totalExercise: $5.46From: 2011-07-01Exp: 2011-07-01→ Common Stock (5,308 underlying)
Footnotes (5)
- [F1]Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
- [F2]Includes shares of common stock acquired from the non-reportable exercise of a Grant under the Qualified Employee Stock Purchase Plan.
- [F3]Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
- [F4]The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date. The number of shares acquired upon exercise is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date.
- [F5]The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the exercise date.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeother
Related Parties
1- filerCIK 0001327414
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:31 PM ET
- Size
- 12.1 KB